A detailed history of Bill Few Associates, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bill Few Associates, Inc. holds 7,579 shares of BDX stock, worth $1.79 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
7,579
Previous 7,389 2.57%
Holding current value
$1.79 Million
Previous $1.73 Million 5.85%
% of portfolio
0.66%
Previous 0.67%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$221.47 - $242.41 $42,079 - $46,057
190 Added 2.57%
7,579 $1.83 Million
Q2 2024

Jul 16, 2024

BUY
$225.07 - $246.17 $64,144 - $70,158
285 Added 4.01%
7,389 $1.73 Million
Q1 2024

Apr 18, 2024

BUY
$233.45 - $247.73 $21,010 - $22,295
90 Added 1.28%
7,104 $1.76 Million
Q4 2023

Jan 16, 2024

SELL
$232.24 - $267.23 $31,352 - $36,076
-135 Reduced 1.89%
7,014 $1.71 Million
Q3 2023

Oct 20, 2023

BUY
$254.9 - $283.59 $70,097 - $77,987
275 Added 4.0%
7,149 $1.85 Million
Q2 2023

Jul 18, 2023

BUY
$238.39 - $265.32 $49,108 - $54,655
206 Added 3.09%
6,874 $1.81 Million
Q1 2023

Apr 17, 2023

BUY
$229.71 - $259.35 $38,591 - $43,570
168 Added 2.58%
6,668 $1.65 Million
Q4 2022

Jan 24, 2023

SELL
$218.29 - $256.91 $61,557 - $72,448
-282 Reduced 4.16%
6,500 $0
Q3 2022

Oct 13, 2022

SELL
$51.03 - $264.23 $408 - $2,113
-8 Reduced 0.12%
6,782 $1.51 Million
Q2 2022

Jul 26, 2022

BUY
$234.74 - $275.42 $14,788 - $17,351
63 Added 0.94%
6,790 $1.67 Million
Q1 2022

Apr 27, 2022

SELL
$243.64 - $270.48 $4,385 - $4,868
-18 Reduced 0.27%
6,727 $1.79 Million
Q4 2021

Mar 04, 2022

BUY
$230.08 - $250.94 $1.55 Million - $1.69 Million
6,745 New
6,745 $1.7 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bill Few Associates, Inc. Portfolio

Follow Bill Few Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill Few Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bill Few Associates, Inc. with notifications on news.